
Join to View Full Profile
4716 Ravendale DrRichardson, TX 75082
Phone+1 972-860-9024
Fax+1 972-525-8845
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Venkatesh Nagaraddi, MD is a board certified neurologist in Richardson, Texas. He is currently licensed to practice medicine in Texas, Iowa, and Tennessee. He is affiliated with Gillette Children's, Intermountain Health Lutheran Hospital, and Intermountain Health Saint Joseph Hospital.
Education & Training
- Cleveland Clinic FoundationFellowship, Clinical Neurophysiology, 2005 - 2006
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2002 - 2005
- AtlantiCare Regional Medical CenterInternship, Internal Medicine, 2001 - 2002
- Kasturba Medical College ManipalClass of 1998
Certifications & Licensure
- CO State Medical License 2019 - 2027
- MT State Medical License 2019 - 2027
- ID State Medical License 2019 - 2027
- SD State Medical License Active through 2027
- UT State Medical License 2019 - 2026
- NM State Medical License 2019 - 2026
- TN State Medical License 2024 - 2026
- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Publications & Presentations
PubMed
- 59 citationsMulti-Biosignal Analysis for Epileptic Seizure Monitoring.Diana Cogan, Javad Birjandtalab, Mehrdad Nourani, Jay Harvey, Venkatesh Nagaraddi
International Journal of Neural Systems. 2017-02-01 - 8 citationsEfficacy of once-daily extended-release topiramate (USL255): A subgroup analysis based on the level of treatment resistanceR. Edward Hogan, Ilan Blatt, Balduin Lawson, Venkatesh Nagaraddi, Toufic Fakhoury
Epilepsy & Behavior. 2014-12-01 - 30 citationsOnce-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.Steve Chung, Toufic Fakhoury, R. Edward Hogan, Venkatesh Nagaraddi, Ilan Blatt
Epilepsia. 2014-07-01